We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LIXT market cap is 4.23M. The company's latest EPS is USD -2.2616 and P/E is -0.82.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.67M | -1.02M | -1.03M | -967k | -1.01M |
| Net Income | -1.67M | -1.02M | -1.03M | -971k | -1.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.49M | -3.27M | -6.72M | -6.31M | -5.09M |
| Net Income | -2.44M | -3.27M | -6.73M | -6.31M | -5.09M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.1M | 5.24M | 4.31M | 3.59M | 2.67M |
| Total Liabilities | 403k | 312k | 314k | 463k | 422k |
| Total Equity | 2.69M | 4.92M | 4M | 3.13M | 2.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.67M | 5.23M | 5.09M | 5.56M | 4.31M |
| Total Liabilities | 238k | 216k | 303k | 395k | 314k |
| Total Equity | 2.43M | 5.01M | 4.79M | 5.17M | 4M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.45M | -3.39M | -4.29M | -789k | -1.61M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 6k | 3.14M | 3.14M | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.67M | -2.13M | -4.14M | -4.61M | -4.29M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | 4.6M | 3.9M | 5.14M | 3.14M |
| Market Cap | 4.23M |
| Price to Earnings Ratio | -0.82 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1 |
| Price to Book Ratio | 1.05 |
| Dividend Yield | - |
| Shares Outstanding | 2.25M |
| Average Volume (1 week) | 15.99k |
| Average Volume (1 Month) | 158.7k |
| 52 Week Change | -9.62% |
| 52 Week High | 4.42 |
| 52 Week Low | 1.55 |
| Spread (Intraday) | 0.23 (11.44%) |
| Company Name | Lixte Biotechnology Holdings Inc |
| Address |
108 west wilmington, delaware 19801 |
| Website | https://lixte.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
